Top member reports
No meetings
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
No value forecast available for this company
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#New Agreement 18/2/21
stale
Added 3 years ago

MEDLAB EXECUTES HEADS OF AGREEMENT WITH ARROTEX (AUSTRALIA’S LARGEST GENERIC/ OTC SUPPLIER) TO ACCELERATE NANOCBD™ ACCESS TO AUSTRALIAN PHARMACY

  •  Development positions NanoCBD™ for pharmacist only medicines schedule (S3)
  •  Medlab’s pharmaceutical standards of safety, stability and dose specifics primed for fast application to TGA registration
  •  NanoCBD™ significantly differentiated by Medlab’s proprietary delivery platform, NanoCelle®

DISC: I have a small holding

View Attachment

Read More